$1.76
+0.08 (+4.76%)
Open$1.73
Previous Close$1.68
Day High$1.83
Day Low$1.71
52W High$40.57
52W Low$1.43
Volume—
Avg Volume41.2K
Market Cap124.71M
P/E Ratio—
EPS$-0.08
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 66.78M | 62.47M | 71.10M |
| Net Income | 5.53M | 4.95M | 5.20M |
| Profit Margin | 8.3% | 7.9% | 7.3% |
| EBITDA | 7.58M | 8.61M | 8.78M |
| Free Cash Flow | 4.38M | 4.03M | 6.15M |
| Rev Growth | +15.6% | -3.5% | +12.7% |
| Debt/Equity | 0.23 | 0.21 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.55 | -0.16% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $456.60 | -1.24% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $169.42 | +1.10% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $531.97 | -1.08% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $951.08 | -0.14% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $159.73 | -3.22% | 7.7 | 20.98B |